SOUTH SAN FRANCISO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will unveil a new custom assay design service for high-sample throughput amplicon resequencing on Illumina platforms at this week’s Advances in Genome Biology and Technology (AGBT) meeting. The Access Array™ Target-Specific Primers, when used with the Fluidigm Access Array System, allow for fast, simple, and inexpensive preparation of up to 480 amplicons per sample at a time. This capability is ideal for analysis of large sample sets across focused genomic regions to better understand human genetic variation.
